United States Food and Drug Administration
"United States Food and Drug Administration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An agency of the PUBLIC HEALTH SERVICE concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
| Descriptor ID |
D014486
|
| MeSH Number(s) |
I01.409.418.750.600.650.760 N03.540.348.500.500.600.650.760
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "United States Food and Drug Administration".
Below are MeSH descriptors whose meaning is more specific than "United States Food and Drug Administration".
This graph shows the total number of publications written about "United States Food and Drug Administration" by people in this website by year, and whether "United States Food and Drug Administration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 0 | 1 | 1 |
| 1998 | 0 | 4 | 4 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 2 | 2 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 5 | 5 |
| 2007 | 3 | 5 | 8 |
| 2008 | 0 | 4 | 4 |
| 2009 | 1 | 5 | 6 |
| 2010 | 0 | 7 | 7 |
| 2011 | 1 | 11 | 12 |
| 2012 | 1 | 6 | 7 |
| 2013 | 1 | 4 | 5 |
| 2014 | 1 | 3 | 4 |
| 2015 | 1 | 4 | 5 |
| 2016 | 1 | 0 | 1 |
| 2017 | 0 | 2 | 2 |
| 2018 | 2 | 10 | 12 |
| 2019 | 2 | 5 | 7 |
| 2020 | 0 | 7 | 7 |
| 2021 | 2 | 7 | 9 |
| 2022 | 0 | 5 | 5 |
| 2023 | 0 | 4 | 4 |
| 2024 | 1 | 6 | 7 |
| 2025 | 1 | 7 | 8 |
| 2026 | 1 | 5 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "United States Food and Drug Administration" by people in Profiles.
-
Integration of community-engaged research technology and methods to guide tobacco regulatory science in rural communities. Front Public Health. 2026; 14:1867960.
-
Ethical Responsibility in the Off-Label Use of AI in Medical Imaging. J Clin Ethics. 2026; 37(2):130-134.
-
US Risk Evaluation and Mitigation Strategies with Elements to Assure Safe Use: A Longitudinal Analysis of REMS Modifications (2008-2022). Drug Saf. 2026 Jul; 49(7):829-841.
-
Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 1, Nutrient Considerations. Adv Nutr. 2026 Apr; 17(4):100583.
-
Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 3, Marketing of Infant Formulas, Breastfeeding Support, Hypoallergenic Formulas, and Nutrition for Preterm Infants. Adv Nutr. 2026 Apr; 17(4):100585.
-
Food and Drug Administration Expert Panel on Infant Formula "Operation Stork Speed" June 2025: Part 2, Regulatory and Safety Considerations. Adv Nutr. 2026 Apr; 17(4):100584.
-
Publicly Available Clinical Trial Safety Data: Review and a Call for Standardization and Improved Reporting Practices. Pharmaceut Med. 2026 03; 40(2):145-161.
-
AI, Health, and Health Care Today and Tomorrow: The JAMA Summit Report on Artificial Intelligence. JAMA. 2025 11 11; 334(18):1650-1664.
-
Potential alternative dosage strategies for patent-protected oral cancer drugs. Eur J Cancer. 2025 Nov 17; 230:116067.
-
Strengthening the Food and Drug Administration Office of Clinical Pharmacology's Labeling Authority. Clin Transl Sci. 2025 09; 18(9):e70337.